SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biodoc who wrote (5438)9/3/1998 1:18:00 PM
From: Claud B  Read Replies (1) of 7041
 
In the case of Aviron, the 60-day period WAS adhered to. Notice
that the company or whomever, listed the submittal date as June 30.
The FDA goes by the day they receive the application. Companies
who submit an NDA get a receipt from the FDA. in Aviron's case
their NDA was probably not received until July 2, or so.

All this is just for clarification purposes regarding this 60-day
rule.

As for Zonagen, the 60 day period expires September 13.

Claud
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News